MedTrace Logo

Long-term Follow up After SG vs RYGB vs OAGB

NCT03467646 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 600

Last updated 2018-03-16

No results posted yet for this study

Summary

A prospective randomized clinical study of all morbidly obese patients undergoing SG, RYGB and OAGB, as primary bariatric procedures, was performed. Patients were randomly assigned into 3 groups: those patients undergoing SG, those ones undergoing RYGB and those ones undergoing OAGB. BMI, excess BMI loss (EBMIL) and remission of type 2 diabetes (T2DM), hypertension (HT) and dyslipidemia (DL) were assessed.

Conditions

Interventions

PROCEDURE

Sleeve Gastrectomy

The patients undergo a Sleeve Gastrectomy as bariatric procedure

PROCEDURE

Roux-en-Y gastric bypass

The patients undergo a Roux-en-Y gastric bypass as bariatric procedure

PROCEDURE

One-Anastomosis Gastric Bypass

The patients undergo a One-Anastomosis Gastric Bypass as bariatric procedure

Sponsors & Collaborators

  • Hospital General Universitario Elche

    lead OTHER

Principal Investigators

  • Miguel Angel Carbajo · Centro de Tratamiento de la Obesidad

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-06-30
Primary Completion
2017-12-31
Completion
2017-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03467646 on ClinicalTrials.gov